9:00AM Case Study: Effective Strategies to Identify, Reduce, & Manage Pre- Existing Antibodies to Expand Patient Eligibility in Gene Therapy
Time: 9:00 am
day: Conference Day 2
Details:
• How prevalent is pre-existing AAV immunity in different patient populations?
• Discuss screening and stratification techniques to identify AAV-positive patients
• Explore approaches like plasmapheresis, vector engineering, and alternative serotypes to bypass antibody response
